Ensign Peak Advisors Inc Trims Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Ensign Peak Advisors Inc trimmed its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 277,064 shares of the company's stock after selling 58,354 shares during the period. Ensign Peak Advisors Inc owned 0.32% of HealthEquity worth $26,584,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of HQY. FORA Capital LLC bought a new position in HealthEquity during the fourth quarter valued at approximately $536,000. Fred Alger Management LLC bought a new position in HealthEquity during the fourth quarter valued at approximately $1,583,000. Frontier Capital Management Co. LLC bought a new position in HealthEquity during the fourth quarter valued at approximately $4,199,000. Deutsche Bank AG boosted its stake in HealthEquity by 25.9% during the fourth quarter. Deutsche Bank AG now owns 118,199 shares of the company's stock valued at $11,341,000 after buying an additional 24,289 shares during the last quarter. Finally, EP Wealth Advisors LLC boosted its stake in HealthEquity by 9.7% during the fourth quarter. EP Wealth Advisors LLC now owns 4,555 shares of the company's stock valued at $437,000 after buying an additional 403 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Trading Up 1.1%

NASDAQ:HQY traded up $1.07 during midday trading on Wednesday, hitting $98.06. The stock had a trading volume of 972,598 shares, compared to its average volume of 793,131. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a market capitalization of $8.48 billion, a price-to-earnings ratio of 89.96, a PEG ratio of 1.60 and a beta of 0.45. The stock has a 50-day moving average of $87.77 and a 200 day moving average of $96.82. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Analysts Set New Price Targets

HQY has been the topic of a number of recent research reports. KeyCorp decreased their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their target price for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Barrington Research reiterated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group cut their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Finally, Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and an average target price of $111.75.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.